Application Nr Approved Date Route Status External Links
ANDA207873 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mesalamine Delayed-Release Capsules Are An Aminosalicylate Indicated For: Treatment Of Mildly To Moderately Active Ulcerative Colitis In Patients 5 Years Of Age And Older ( 1.1 ) Maintenance Of Remission Of Ulcerative Colitis In Adults ( 1.2 ) 1.1 Treatment Of Mildly To Moderately Active Ulcerative Colitis Mesalamine Delayed-Release Capsules Are Indicated For The Treatment Of Mildly To Moderately Active Ulcerative Colitis In Patients 5 Years Of Age And Older. 1.2 Maintenance Of Remission Of Ulcerative Colitis Mesalamine Delayed-Release Capsules Are Indicated For The Maintenance Of Remission Of Ulcerative Colitis In Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments